What is angiosarcomas? What are the various angiosarcomas treatment available today?

 

Angiosarcomas Treatment

Angiosarcomas tend to invade adjacent tissue and therefore, complete excision is challenging. To improve Angiosarcomas treatment outcomes, some studies have used a multimodality approach, combining surgery, radiation therapy, and chemotherapy. In a recent retrospective study, 55 patients with angiosarcoma of the face underwent chemotherapy, radiation therapy, or a combination of these treatments. Patients who received multimodality therapy had a favorable response rate to local-regional control and longer overall survival.

According to Coherent Market Insights the Angiosarcomas Treatment Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.

Molecular markers are a common way to detect angiosarcoma. CD31, CD34, factor VIII-related antigen (Fli-1), and ERG are markers that are specific for this cancer. Positive results in any one of these markers may be helpful in distinguishing between epithelioid and non-epithelioid angiosarcomas. In addition to standard markers, several ongoing studies focus on identifying specific genetic alterations and molecular markers that may be associated with angiosarcoma.

The most common angiosarcoma treatment is surgery. This procedure removes the tumor and surrounding healthy tissue and may be followed by radiotherapy. If the tumor is too large, surgery is not a viable option. However, this type of treatment is effective for small angiosarcomas that do not spread widely. In addition to surgery, some doctors also use radiation therapy around the surgical site to prevent the tumor from growing after it is removed. Early diagnosis is essential to reduce the risk of recurrence or death. There are various diagnostic tests for angiosarcoma, but the most effective way to find the disease is to perform a physical exam. It will be helpful to know the risk factors before starting treatment. Standard treatment consists of surgery, radiation therapy, and chemotherapy. However, the results of treatment are dependent on tumor site, size, and resectability. In addition, some studies have shown that targeted medicines and immunotherapy have the potential as treatments for angiosarcomas.